$INBX

Inhibrx Inc

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$13.65 -

Extented Hours

VOLUME

272,211

DAY RANGE

12.6 - 13.68

52 WEEK

11.56 - 47.9

Join Discuss about INBX with like-minded investors

profile
@dros #droscrew
recently

921k $INBX @ $45

119 Replies 11 👍 8 🔥

profile
@dros #droscrew
recently

+Initiations 9/21: $ATLC $CANO $CMCSA $CTRN $DIS $DNLI $EFTR $ENPH $EVGO $FINV $FTNT $GOSS $HLMN $INBX $ISOS $JEF $LIFE $MDLZ $NEP $PIPR $PLXP $PNTG $PRTG $RXRX $TDAC $TMUS $UNVR . -Initiations 9/21: $COWN

126 Replies 11 👍 12 🔥

profile
@ITA_TRADE #decarolis
recently

Vorrei sapere se qualcuno sta seguendo la vicenza INBX

134 Replies 7 👍 7 🔥

Key Metrics

Market Cap

532.86 M

Beta

1.90

Avg. Volume

527.06 K

Shares Outstanding

39.04 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-09

Next Dividend Date

Company Information

Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. Inhibrx has collaborations with bluebird bio, Bristol-Myers Squibb and Chiesi.

Website:

HQ: 11025 N. Torrey Pines Road, Suite 200 La Jolla, 92037 California

Related News